Flexion Therapeutics, known for its slogan "Transformative Medicine...Where It Matters", is a biopharmaceutical company dedicated to innovative solutions for musculoskeletal conditions. Founded in 2007 and headquartered in Burlington, Massachusetts, the company aligns its operations within the Biotechnology, Health Care, and Health and Wellness sectors.
They have carved a niche in the discovery, development, and commercialization of novel, localized therapies that provide targeted treatment options for patients.
The company's last strategic financial move involved a $30.00M Post-IPO Debt investment on August 4, 2015. This funding round attracted investments from MidCap Financial and Silicon Valley Bank, indicating a vested interest from prominent financial players in Flexion's growth potential.